Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

Activity Description and Educational Objectives

In this activity, an expert on pharmacy-related issues in cancer care provides a pharmacist's perspective on the clinical development and treatment of VOD, and discusses evidence-based dosing and key safety considerations relevant for the management of VOD in HSCT recipients.

Upon completion of this activity, participants will be able to:

• Cite risk factors and preventive and treatment options for veno-occlusive disease (VOD) in cancer patients receiving hematopoietic stem-cell transplant (HSCT)
• Summarize pharmacy-based strategies for accessing novel and/or emerging treatment options for VOD in the HSCT setting
• Select appropriate, evidence-based dosing for VOD treatment strategies
• Recognize potential safety considerations with established and emerging strategies for the management of VOD

Target Audience

This activity has been designed to meet the educational needs of oncology pharmacists, advanced practice oncology nurses, and other clinicians involved in the management of cancer patients.
**Please note that this activity is only being offered for Pharmacist credit on PowerPak.com**

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CE/CPE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: May 27, 2016 - May 26, 2017
Time to Complete: 60 minutes

Faculty & Disclosure/Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE/CPE activity for any amount during the past 12 months.

Course Director

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA
Associate Professor, Hematology/Medical Oncology
Associate Professor, Pharmacology
Emory University School of Medicine
Director, Phase 1 Clinical Trials Section
Winship Cancer Institute of Emory University
Atlanta, Georgia

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, has no financial interests/relationships or affiliations in relation to this activity.

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, does intend to discuss either non−FDA-approved or investigational use for the following products/devices: defibrotide.

Nurse Reviewer

Suzanne M. Costello, RN, MSN, AOCNS
BMT Program Manager
Columbia University Medical Center
New York, New York

Suzanne M. Costello, RN, MSN, AOCNS, has no financial interests/relationships or affiliations in relation to this activity.

CPE Reviewer

Patricia A. Ensor, RPh, MBA
Senior Advisor
Kantar Health
Horsham, PA

Patricia A. Ensor, RPh, MBA, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CE/CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

Pharmacists
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this application-based activity provides for 1.0 contact hours (0.1 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-16-006-H01-P.

Providership
This CE/CPE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support
This activity is supported by an educational grant from Jazz Pharmaceuticals plc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2016, PeerView Press - Medical Education Resource